Unique ID issued by UMIN | UMIN000035584 |
---|---|
Receipt number | R000040551 |
Scientific Title | Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial |
Date of disclosure of the study information | 2019/01/23 |
Last modified on | 2023/07/24 15:58:59 |
Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial
CATCH trial
Continuous Administration of Tranexamic acid for acute intra Cerebral Hemorrhage: a hospital-based trial
CATCH trial
Japan |
Intra cerebral hemorrhage
Neurosurgery |
Others
NO
We search an effect of 14 days continuous administration of tranexamic acid for nonsurgical acute intra cerebral hemorrhage.
Safety,Efficacy
Glasgow Coma Scale at 1 week and at discharge
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
We assigned the patients to one group given 750 mg/day of tranexamic acid for 14 days.
Not applicable |
Not applicable |
Male and Female
the patients who undergo nonsurgical treatment of spontaneous intracerebral hemorrhage
GCS <9; treatment window >8h; intracerebral hemorrhage secondary to anticoagulation, thrombolysis, trauma, or a known underlying structural abnormality; patients for whom tranexamic acid was thought to be contraindicaterd; prestroke mRS >4; patients who receive surgical treatment; multiple intracerebral hemorrhage
30
1st name | Hirotaka |
Middle name | |
Last name | Inoue |
Graduate School of Medical Sciences, Kumamoto University
Departments of Neurosurgery
8608556
1-1-1, Honjo, Chuo-ku, Kumamoto City, Kumamoto, Japan
096-373-5219
hiro2866@gmail.com
1st name | Yuri |
Middle name | |
Last name | Iwasaki |
Hitoyoshi Medical Center
Clinical research center
8688555
35 Roujin-cho Hitoyoshi, Kumamoto, Japan
0966-22-2191
iwasaki-yuri@hitoyoshi.jcho.go.jp
Departments of Neurosurgery, Hitoyoshi Medical Center
none
Other
Hitoyoshi Medical Center
35 Roujin-cho Hitoyoshi, Kumamoto, Japan
0966-22-2191
iwasaki-yuri@hitoyoshi.jcho.go.jp
NO
2019 | Year | 01 | Month | 23 | Day |
https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi
Unpublished
now analyzing
35
Ninety patients comprised the non-administration group. Univariate analysis showed that the mRS score on day 90 was better in the administration group. The mRS scores on the day of death or discharge suggested a favorable effect of tranexamic acid treatment. Multivariable logistic regression analysis showed that tranexamic acid treatment resulted in good mRS scores at day 90.
2021 | Year | 07 | Month | 22 | Day |
age, sex, ICH location, ICH size, intraventricular hemorrhage (IVH) measurement (Modified Graeb Score), pre-onset mRS score, GCS score at admission, and antithrombotic drug history
The prognosis was investigated until 90 days later.
none
The primary outcome was mRS score on day 90. The secondary outcomes included hematoma expansion on day 2, GCS score on day 7, and mRS score on the day of death or hospital discharge (whichever came first).
Completed
2018 | Year | 08 | Month | 05 | Day |
2018 | Year | 08 | Month | 08 | Day |
2018 | Year | 08 | Month | 08 | Day |
2019 | Year | 12 | Month | 31 | Day |
2019 | Year | 01 | Month | 18 | Day |
2023 | Year | 07 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040551
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |